Colposcopy Market

Global Colposcopy Market Size (2023 to 2028)

The global colposcopy market is expected to grow at a CAGR of 5.3% during the forecast period. As a result, the market size is expected to be worth USD 604.9 million in 2023 and USD 783.2 million by 2028.

The term "colposcope" refers to a diagnostic tool that gives the doctor the necessary magnification for a clearer view of the cervix or vagina. The main objective of a colposcopic diagnostic is to locate and effectively treat precancerous lesions at an early stage. They are used for people with cervical cancer but also to check for disorders like cervix abnormalities and immunosuppression. According to the current situation, 530,000 new instances of cervical cancer are found each year. This year, the national incidence rate rose to 12 percent.

Due to its great precision, versatility, simplicity of use, and non-invasive approach, colposcopy is a very effective procedure for early diagnosis of lesions and choosing biopsy sites. Additionally, it enables a magnified examination of the cervix and lower vaginal tract for epithelial lesions that are dysplastic or cancerous. For many years, gynecological examinations required a lengthy and inconvenient clinical procedure that included outdated technology and an uncomfortable visit. But this industry has seen considerable technological breakthroughs in recent years. As a result, major market participants have been implementing cutting-edge technology by merging various digital platforms with colposcopy equipment.

Impact of COVID-19 on the global colposcopy market:

The global spread of the COVID-19 pandemic has disrupted the range of cancer treatments in 2020. In addition, the epidemic has influenced many facets of cancer care and research since many nations have ranked cancer screening and treatment as a relatively low-priority service. For instance, the Scottish government paused cervical, bowel, and breast cancer screening programs and postponed cancer-related procedures. Therefore, the short-term results of colposcopy diagnosis and surgery will suffer due to COVID-19's unusual effect.

MARKET DRIVERS:

Colposcopy technology breakthroughs and a constantly expanding elderly population along with digital imaging, for instance, are used in DYSIS colposcopy to define areas of high-grade illness more precisely on the cervix. As a result, with intuitive functionality, the testing process is quick, simple, accurate, and highly efficient, increasing the product's demand. Additionally, emerging nations are concentrating on expanding the reach of cancer screening programs, which is anticipated to increase colposcopy usage and fuel colposcopy market growth. 

Growing cases of cervical cancer to boost the colposcopy market growth. The market's growth is anticipated to be boosted by elements like the rising prevalence of cervical cancer and the increased demand for early detection methods. According to the Global Cancer Observatory, there were 341,831 cervical cancer-related deaths in 2020, and an estimated 604,127 new instances of the patients of cervical cancer were detected worldwide. Additionally, it is anticipated that by 2025, there will be 1,495,211 new cases of cervical cancer.

MARKET RESTRAINTS:

High colposcopy costs could cause the colposcopy market value to decline. In the upcoming years, market expansion may be slowed by the high cost of colposcopes and the associated procedure. For instance, a colposcope can cost between USD 2,000 and 8,000. Furthermore, depending on whether a biopsy is performed as part of the process, the cost of the colposcopy procedure might range from USD 100 to USD 500 or more. Therefore, rising product and method costs could eventually reduce market demand. In addition, during the projection period, lower insurance coverage for cancer treatment in developing economies may further restrain the market’s growth rate.

REPORT COVERAGE:

This research report on the global colposcopy market has been segmented and sub-segmented based on modality, application, portability, end-user, and region.

Global Colposcopy Market - By Modality:

• Video 
• Optical

The optical colposcope segment dominated the market by holding the most outstanding revenue share of 65.4% in 2022. The optical colposcope has the same three components as a conventional colposcope: the head, which houses the optics; the light source; and the body, which may or may not be moveable. In poorer nations, the optical colposcope is widely used. The main driving forces in this market sector include high affordability and low maintenance. During the forecast period, it is predicted that the video colposcope segment will increase at the fastest rate. The video modality's visual clarity and moving images aid in precise diagnosis. Video colposcopes can autofocus the image if kept between 25 and 30 cm from the target. 

Global Colposcopy Market - By Application:

• Oral
• Pelvic

In 2022, the pelvic examination segment dominated the market which had a share of 79.8%. Over the forecast period, the category is expected to maintain its dominance. The rise in gynecological disease cases brings this on. In addition, colposcopy aids in more precisely pinpointing the issue when a pap smear result is abnormal. 

Global Colposcopy Market - By Probability:

• Stationary
• Handheld

With a market share of 59% in 2022, the stationary colposcope segment led the industry. Stationary colposcopes are popular in developing nations where the adoption of new technology is sluggish. 

During the projection period, the handheld colposcope segment will experience the quickest CAGR of 5.99%. Handheld colposcopes are more widely used in smaller clinics due to their portability, simplicity of use, and compact design. In addition, handheld colposcopy systems can also be brought to a patient's home from the hospital. It increases patient access by allowing gynecological examinations anywhere.

Global Colposcopy Market - By End-Use:

• Diagnostic Centers
• Specialty Clinics
• Hospitals
• Gynecology Clinic
• Ambulatory Surgical Centre
• Research And Academics

The hospital sector had the most significant share of 29.8% of the global colposcopy market in 2022, and it is anticipated that it will maintain its lead throughout the projected period. Because hospitals are well-equipped with the tools needed to screen the cervix for precancerous and cancerous growths, many patients visit hospitals.

Global Colposcopy Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Due to an increase in the incidence of cervical cancer and an increase in healthcare spending, North America held the most outstanding share of 31.4% in the global colposcopy market in 2022. Colposcopy equipment usage, simple access to medical technology, and the existence of substantial distribution channels are all anticipated to support market expansion. The Centers for Medicare and Medicaid Services estimate that in 2020, the U.S. government will spend nearly USD 4.1 trillion on healthcare, or almost 19.7 percent of the nation's GDP.

The market in the Asia Pacific is anticipated to grow at the quickest rate during the projected period due to the region's huge patient base and expanding need for technologically sophisticated and affordable healthcare solutions. Additionally, a rise in hospital admissions and significant advancements in the clinical development framework of developing countries like India, Japan, Korea, and China support market progress in this area.

KEY MARKET PLAYERS:

There are several significant players in the colposcopy market across the world. Here are a few key players, DySIS, CooperSurgical, Olympus, McKesson, Atmos, Danaher Corporation, Karl Kaps, Carl Zeiss, Philipps Healthcare, Bovie Medic, Seliga Microscopes, etc.

Recent Market Developments:

• In June 2022, A prospective study published in the International Scientific Research Journal found that colposcopy could detect endocervicitis in roughly one-third of women with uterine fibroids.
• The Uzbek study examined 100 women who had either undergone total hysterectomy surgery or received no surgery to determine the position of the cervix and the strategies of cervical pathology. Exoservicitis is inflammation of the cervix and the mucous membrane of the cervical canal.
• In June 2022, Treatment guidelines for pre-invasive vulvar lesions were developed by four worldwide medical associations and published in the Journal of Lower Genital Tract Disease. The publication is a component of Wolters Kluwer's Lippincott portfolio.
• A region of skin or mucosa that has the potential to develop into invasive malignancy (cancer) but has not yet done so is known as a pre-invasive vulvar lesion. The recommendations' principal author, Mario Preti, MD, of the University of Torino in Italy, and his co-authors state that pre-invasive vulvar lesions "deserve specific attention because, aside from the oncological risk, they impair not only functionality and body image but also psychosexual variables.”